Proceedings of the Ninth International Conference of Drug Regulatory Authorities (ICDRA) - Berlin, Germany 25-29 April 1999
(1999; 102 pages) View the PDF document
Table of Contents
Open this folder and view contentsOpening Ceremony
Open this folder and view contentsGood regulatory practice
Open this folder and view contentsGood certification practice
Open this folder and view contentsCounterfeit drugs: challenges and solutions
Open this folder and view contentsCurrent issues in regulation and quality
Open this folder and view contentsInternational Conference on Harmonization: implementation and implications
Open this folder and view contentsDrug utilization studies
Open this folder and view contentsInternational Conference on Harmonization and the common technical document
Open this folder and view contentsKeynote address
Open this folder and view contentsGlobal and national efforts to reduce tobacco use
Open this folder and view contentsElectronic communication in the regulatory process
Open this folder and view contentsTransparency in monitoring the safety of medicines
Open this folder and view contentsPharmaceutical products for use in special groups
Open this folder and view contentsNeed for Bioequivalence
Close this folderAntimicrobial resistance: battling the bugs
View the documentCountry experience in implementing antimicrobial resistance strategies
View the documentVeterinary, aquaculture and agricultural use’ of antimicrobials contributing to resistance
View the documentThe role of regulators in the containment of resistance
View the documentRecommendations
Open this folder and view contentsSafety issues of plasma-derived medicinal products
Open this folder and view contentsHerbal medicines
Open this folder and view contentsRegulation and access to essential drugs
View the documentParticipants
View the documentBack cover
 

Antimicrobial resistance: battling the bugs

Moderators: Dr A. Broekmans, Netherlands, and Dr E. Gabrielian, Armenia

The emergence and spread of antimicrobial resistance poses a major challenge to the quality and cost of healthcare systems worldwide. Effective interventions are urgently needed to contain emerging resistance - without these the problem will inevitably worsen, with dramatic human and financial consequences. The WHO Global Strategy for the Containment of Antimicrobial Resistance provides a practical framework and helps to prioritize those interventions that are likely to be most effective.

The future containment of antimicrobial resistance requires a coordinated multidimensional approach in which effective change in antimicrobial usage, infection control and epidemiologically-sound resistance surveillance are key objectives. The WHO Global Strategy aims to fulfil these goals.

to previous section to next section
 

Last updated: April 24, 2012